玻璃体内注射-话题@MedSci

#玻璃体内注射#

13篇内容 | 1203人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2121044, encodeId=c8a421210445e, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a><a href='/topic/show?id=6391494e078' target=_blank style='color:#2F92EE;'>#康柏西普#</a>辅助<a href='/topic/show?id=eaa71056927d' target=_blank style='color:#2F92EE;'>#玻璃体切除治疗#</a>增殖性<a href='/topic/show?id=bb09e67752b' target=_blank style='color:#2F92EE;'>#糖尿病视网膜病变#</a>的网络Meta分析, objectTitle=Front Endocrinol：玻璃体内注射康柏西普辅助玻璃体切除治疗增殖性糖尿病视网膜病变的网络Meta分析, objectType=article, longId=763088, objectId=7638e6308800, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/Random/267914-eye.jpg, objectUrl=/article/show_article.do?id=7638e6308800, replyNumber=0, likeNumber=119, createdTime=2023-03-22, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=7638e6308800, moduleTitle=Front Endocrinol：玻璃体内注射康柏西普辅助玻璃体切除治疗增殖性糖尿病视网膜病变的网络Meta分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7638e6308800)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745758, encodeId=611c1e457580c, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=JAMA Ophthalmol：玻璃体内注射VEGF抑制剂阿柏西普对糖尿病视网膜病变视力减退的预防作用, objectType=article, longId=209409, objectId=ebae2094096b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ebae2094096b, replyNumber=0, likeNumber=94, createdTime=2022-01-06, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ebae2094096b, moduleTitle=JAMA Ophthalmol：玻璃体内注射VEGF抑制剂阿柏西普对糖尿病视网膜病变视力减退的预防作用, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ebae2094096b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745757, encodeId=5b1b1e45757d8, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=BMC Ophthalmol：玻璃体内注射Ranibizumab后出现人疱疹病毒-6相关的角膜内皮炎并发症, objectType=article, longId=160214, objectId=cdeb160214fa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cdeb160214fa, replyNumber=0, likeNumber=82, createdTime=2019-12-20, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cdeb160214fa, moduleTitle=BMC Ophthalmol：玻璃体内注射Ranibizumab后出现人疱疹病毒-6相关的角膜内皮炎并发症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cdeb160214fa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745756, encodeId=959e1e4575671, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读, objectType=article, longId=157503, objectId=8f8415e503af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f8415e503af, replyNumber=0, likeNumber=68, createdTime=2019-08-22, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f8415e503af, moduleTitle=玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f8415e503af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745755, encodeId=6ca01e4575508, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=Eur J Ophthalmol：玻璃体内注射超低剂量雷珠单抗治疗早产1型视网膜病变的疗效, objectType=article, longId=153884, objectId=507c153884ca, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=507c153884ca, replyNumber=0, likeNumber=84, createdTime=2019-04-02, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=507c153884ca, moduleTitle=Eur J Ophthalmol：玻璃体内注射超低剂量雷珠单抗治疗早产1型视网膜病变的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=507c153884ca)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745753, encodeId=14541e45753cd, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=Graefes Arch Clin Exp Ophthalmol：玻璃体内注射贝伐单抗治疗可减少早产儿视网膜病变中的眼部血流, objectType=article, longId=144470, objectId=03db1444e0a6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=03db1444e0a6, replyNumber=0, likeNumber=87, createdTime=2019-06-24, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=03db1444e0a6, moduleTitle=Graefes Arch Clin Exp Ophthalmol：玻璃体内注射贝伐单抗治疗可减少早产儿视网膜病变中的眼部血流, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=03db1444e0a6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745754, encodeId=faac1e45754ef, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=PLoS One：向非肥胖糖尿病小鼠的玻璃体内注射促炎细胞因子建立糖尿病视网膜病变新模型, objectType=article, longId=147574, objectId=dd4f14e574ab, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dd4f14e574ab, replyNumber=0, likeNumber=84, createdTime=2019-07-31, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dd4f14e574ab, moduleTitle=PLoS One：向非肥胖糖尿病小鼠的玻璃体内注射促炎细胞因子建立糖尿病视网膜病变新模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dd4f14e574ab)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745750, encodeId=7f8f1e45750f0, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=2018 EURETINA专家共识建议：玻璃体内注射（更新版）, objectType=article, longId=128964, objectId=e3da1289640d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e3da1289640d, replyNumber=0, likeNumber=53, createdTime=2018-04-30, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e3da1289640d, moduleTitle=2018 EURETINA专家共识建议：玻璃体内注射（更新版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e3da1289640d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745749, encodeId=d4aa1e4574917, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=Sci Rep：玻璃体内注射抗VEGF药物和预防眼内炎的抗生素：系统分析研究, objectType=article, longId=125217, objectId=97ef12521e5e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=97ef12521e5e, replyNumber=0, likeNumber=94, createdTime=2018-10-23, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=97ef12521e5e, moduleTitle=Sci Rep：玻璃体内注射抗VEGF药物和预防眼内炎的抗生素：系统分析研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=97ef12521e5e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745752, encodeId=00d61e457525a, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=2018 临床实践指南：玻璃体内注射抗血管内皮生长因子药物治疗眼部血管疾病, objectType=article, longId=137396, objectId=16d913e3966a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16d913e3966a, replyNumber=0, likeNumber=55, createdTime=2018-08-20, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16d913e3966a, moduleTitle=2018 临床实践指南：玻璃体内注射抗血管内皮生长因子药物治疗眼部血管疾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=16d913e3966a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745751, encodeId=34651e457515f, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=Ophthalmologica：地塞米松玻璃体内注射治疗糖尿病性黄斑水肿患者的临床决策, objectType=article, longId=134586, objectId=82cb1345863b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=82cb1345863b, replyNumber=0, likeNumber=79, createdTime=2019-03-15, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=82cb1345863b, moduleTitle=Ophthalmologica：地塞米松玻璃体内注射治疗糖尿病性黄斑水肿患者的临床决策, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=82cb1345863b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745747, encodeId=84c51e4574792, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=Invest Ophthalmol Vis Sci：PET可以作为非侵入性的手段来研究玻璃体内注射的药代动力学特征！, objectType=article, longId=100608, objectId=0a261006081d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0a261006081d, replyNumber=0, likeNumber=73, createdTime=2018-01-08, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0a261006081d, moduleTitle=Invest Ophthalmol Vis Sci：PET可以作为非侵入性的手段来研究玻璃体内注射的药代动力学特征！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0a261006081d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1745748, encodeId=e0b11e4574889, content=<a href='/topic/show?id=79ab685899e' target=_blank style='color:#2F92EE;'>#玻璃体内注射#</a>, objectTitle=Ophthalmologica: 渗出性年龄相关黄斑变性在玻璃体内注射雷珠珠单抗3个月后再治疗！, objectType=article, longId=117024, objectId=34fd11e02429, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=34fd11e02429, replyNumber=0, likeNumber=72, createdTime=2018-09-27, rootId=0, userName=cathymary, userId=6da635562893, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=34fd11e02429, moduleTitle=Ophthalmologica: 渗出性年龄相关黄斑变性在玻璃体内注射雷珠珠单抗3个月后再治疗！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=34fd11e02429)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

玻璃体内注射

2020-05-29

侠胆医心 (审核中...)

前往app查看评论内容

#玻璃体内注射##康柏西普#辅助#玻璃体切除治疗#增殖性#糖尿病视网膜病变#的网络Meta分析

Front Endocrinol：玻璃体内注射康柏西普辅助玻璃体切除治疗增殖性糖尿病视网膜病变的网络Meta分析

2023-03-22发表于上海

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

JAMA Ophthalmol：玻璃体内注射VEGF抑制剂阿柏西普对糖尿病视网膜病变视力减退的预防作用

2022-01-06

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

BMC Ophthalmol：玻璃体内注射Ranibizumab后出现人疱疹病毒-6相关的角膜内皮炎并发症

2019-12-20

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

玻璃体内注射技术规范——2018 年欧洲视网膜专家学会共识解读

2019-08-22

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

Eur J Ophthalmol：玻璃体内注射超低剂量雷珠单抗治疗早产1型视网膜病变的疗效

2019-04-02

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

Graefes Arch Clin Exp Ophthalmol：玻璃体内注射贝伐单抗治疗可减少早产儿视网膜病变中的眼部血流

2019-06-24

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

PLoS One：向非肥胖糖尿病小鼠的玻璃体内注射促炎细胞因子建立糖尿病视网膜病变新模型

2019-07-31

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

2018 EURETINA专家共识建议：玻璃体内注射（更新版）

2018-04-30

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

Sci Rep：玻璃体内注射抗VEGF药物和预防眼内炎的抗生素：系统分析研究

2018-10-23

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

2018 临床实践指南：玻璃体内注射抗血管内皮生长因子药物治疗眼部血管疾病

2018-08-20

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

Ophthalmologica：地塞米松玻璃体内注射治疗糖尿病性黄斑水肿患者的临床决策

2019-03-15

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

Invest Ophthalmol Vis Sci：PET可以作为非侵入性的手段来研究玻璃体内注射的药代动力学特征！

2018-01-08

cathymary (审核中...)

前往app查看评论内容

#玻璃体内注射#

Ophthalmologica: 渗出性年龄相关黄斑变性在玻璃体内注射雷珠珠单抗3个月后再治疗！

2018-09-27

科室
- - 订阅+
  - 更多科室
工具
服务